Our findings emphasize the significance of HIF-1α, VEGFa, NF-κB and Gal-1 signaling pathways in the implementation of novel treatment techniques against drug-resistant cancers; especially sorafenib-resistant ones. The gene discussed is HIF1A; the disease is cancer.